|
Informa Biomedical
and Pharmaceutical is a leading producer of business titles and conferences
for the over-the-counter (OTC) and prescription pharmaceutical industries.
Steel4's Al Smith was
asked by the editor of E-health Business to cover and report on a
two-day conference in London looking at the implications of the Internet and
technology on the global healthcare industry.
"It
is so nice to get a conference report from somebody who picks out the salient
points, rather than says speaker one said this, speaker 2 said that, speaker 3
..."
Editor,
E-health Business / Pharmaceutical Business News
Read the e-Health Business report (pdf
279kb)
On the back of his work for E-health Business, Al went
on to edit and write copy for Informa's OTC Business News (later,
Self-Medication International), a fortnightly newsletter providing global
coverage of the over-the-counter pharmaceutical and self-medication
industries.
 |
Schering-Plough
sets the scene for OTC anti-allergy battle
Schering-Plough
has announced it is seeking approval from the Food and Drug Administration
(FDA) for the Rx-to-OTC switch of all versions
its best-selling
antihistamine Claritin, prior to the expiry of its patent on 19 December
2002. The company said it wanted to introduce a safe ...
Read the issue in full (PDF 222kb) |
| |
|
|
|
|
GSK loses no.2
spot whilst Far East shows promise
Johnson & Johnson
remained the leading OTC manufacturer during
2001, increasing
its sales by 2.6 per cent to $1.72 billion (£1.19 billion), according to
market research specialist IMS Health. Including estimates of non-audited
countries and channels, the market as a whole grew by ...
Read the issue in full (PDF 310kb) |
| |
|
|
|
|
